China NT Pharma Group Co., Ltd. (1011)
Market Open
12 Aug, 08:00
HKEX HKEX Primary 0. 34
HKD 0
0%
552.88M Market Cap
- P/E Ratio
- Div Yield
46,050 Volume
- Eps
0.34 HKD
Previous Close Want to track 1011 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
China NT Pharma Group Co., Ltd. (1011) Statistics
Valuation metrics
Market Cap 552.88M
Enterprise value 523.79M
Trailing P/E (ttm) -7.45
Forward P/E 5.55
PEG ratio -0.14
Price/Sales (ttm) 8.87
Price/Book (mrq) -0.8
Enterprise Value/Revenue 21.68
Enterprise Value/EBITDA -42.53
Overview
Shares outstanding 674.25M
Float 136.05M
Shares short -
% Held by insiders 0.85%
% Held by institutions -
Average volume (10 days) 48.52K
Average volume (90 days) 162.48K
Price summary
52-Week low 0.3
52-Week high 1.35
Beta -1.97
50-Day moving average 0.39
200-Day moving average 0.6
Dividends and splits
Forward annual dividend rate 1.4
Forward annual dividend yield 2.2951%
Trailing annual dividend rate 0.35
Trailing annual dividend yield 0.5738%
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 3 Jul 2024
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 30 Jun 2018
Profitability
Profit margin -1.08%
Operating margin -0.51%
Operational effectiveness
Return on assets -0.07%
Return on equity 0.09%
Income Statement
Revenue (ttm) 27.79M
Revenue per share (ttm) 0.04
Quarterly revenue growth (yoy) 0.82%
Gross profit (ttm) 11.05M
EBITDA -14.17M
Net income to common (ttm) -29.96M
Diluted EPS (ttm) -0.04
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 8.31M
Total cash per share (mrq) 0.01
Total debt (mrq) 364.31M
Total Debt/Equity (mrq) -1.16
Current ratio (mrq) 0.02%
Book value per share (mrq) -0.41
Cash Flow
Cash flow statement 203K
Levered free cash flow (LFCF) -26.04M
